vTv Therapeutics (VTVT) Tops Q1 EPS by 5c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• SanDisk stock target lifted at Bernstein to $3000 on new memory LTAs
• Rodman & Renshaw Starts vTv Therapeutics (VTVT) at Buy
• Logitech dips as BofA downgrades stock on demand outlook concerns